Legend Biotech (LEGN) Debt Ratio (2021 - 2026)

Legend Biotech (LEGN) has 6 years of Debt Ratio data on file, last reported at 0.17 in Q1 2026.

• Quarterly Debt Ratio fell 11.97% year-over-year to 0.17 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.17 (down 11.97% YoY) and the FY2025 annual result came in at 0.37, up 104.13% from the prior year.
• Debt Ratio fell to 0.17 in Q1 2026, from 0.37 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.37 in Q4 2025 to a low of 0.14 in Q2 2023.
• A 5-year average of 0.19 and a median of 0.18 in 2024 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2024 — Debt Ratio declined 26.61% — and 2025, when it soared 104.13%.
• Tracing LEGN's Debt Ratio over 5 years: stood at 0.2 in 2022, then slipped by 22.37% to 0.15 in 2023, then grew by 18.5% to 0.18 in 2024, then soared by 104.13% to 0.37 in 2025, then sank by 54.74% to 0.17 in 2026.
• The last three Debt Ratio figures came in at 0.17 (Q1 2026), 0.37 (Q4 2025), and 0.18 (Q3 2025), per Business Quant data.